Options for mRCC After Nivolumab

Options for mRCC After Nivolumab

UROwebinar: Management of Metastatic kidney cancerПодробнее

UROwebinar: Management of Metastatic kidney cancer

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCCПодробнее

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCC

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCCПодробнее

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

Immunotherapy in Renal Cell CarcinomaПодробнее

Immunotherapy in Renal Cell Carcinoma

Targeted therapies for the treatment of mRCC after nivolumab-ipilimumab failureПодробнее

Targeted therapies for the treatment of mRCC after nivolumab-ipilimumab failure

Frontline Therapy Options for mRCCПодробнее

Frontline Therapy Options for mRCC

New and Emerging Systemic Treatment Options for Metastatic Kidney Cancer Scott S. Tykodi, M.D., PhD.Подробнее

New and Emerging Systemic Treatment Options for Metastatic Kidney Cancer Scott S. Tykodi, M.D., PhD.

Managing Advanced Renal Cell Carcinoma - QuinnПодробнее

Managing Advanced Renal Cell Carcinoma - Quinn

Новости